Breakthrough T1D ✓

@BreakthroughT1D · Headquarters in New York, NY · joined 25 Feb 2009

As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it. We are Breakthrough T1D.

62 748Followers

1 539Following

13 776Posts total

15.5KViews on collected posts

โพสต์ล่าสุด

Breakthrough T1D ✓@BreakthroughT1D17 Sep

Breaking news: for the first time in 30 years, there’s a new approved therapy for kidney disease in T1D. Today, the FDA approved finerenone (brand name Kerendia) to treat chronic kidney disease (CKD) associated with T1D. CKD is one of the most common complications of T1D—nearly 2.3K views · 17 likes · 5 reposts · 1 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D16 Sep

De la Detección Temprana a la Investigación Clínica: Avances en Diabetes Tipo 1 https://t.co/9T67veKZGY 1.4K views · 2 likes · 2 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D16 Sep

Last March, Breakthrough T1D sent a proposal to the Department of Health and Human Services (HHS) to reclassify deceased donor islets (DDIs) as organs rather than drugs. After months of engagement across HHS, the department has taken action. Today, the Food and Drug https://t.co/

1.8K views · 10 likes · 2 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D10 Sep

Until now, clinicians have lacked concrete guidance on who, when, and how to screen for type 1 diabetes (T1D). Led by Breakthrough T1D, experts around the globe have provided practical guidance for screening. Learn more here: https://t.co/v1z4RkXbsc https://t.co/VMSrUEi2TB

2.8K views · 15 likes · 4 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D9 Sep

If you or a loved one lives with type 1 diabetes (T1D) and has been impacted by Hurricane Lowell, visit the link below to learn more about available resources! Stay safe! 💙 https://t.co/9Np1XBKztk 1.5K views · 5 likes · 0 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D4 Sep

An exciting step forward for cell therapies! Swipe to learn the latest, and be sure to stay tuned to learn more! Want to learn more about the research we’re funding? Visit the link below! https://t.co/LhAXTQ7LYb https://t.co/WtDRc27tiL

1.6K views · 24 likes · 4 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D3 Sep

Thank you, Representatives @RepDianaDeGette, @RepMMM, @RepKimSchrier, @RepBresnahan, and @RepAngieCraig for leading the charge in the House on insulin affordability by introducing the bipartisan INSULIN Act of 2026. Insulin isn’t a choice; it’s a necessity. That’s why 1.9K views · 21 likes · 7 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D3 Sep

@BreakthroughT1D Feels like a “five years away” promise again.. 45 views · 0 likes · 0 reposts · 1 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D2 Sep

@BreakthroughT1D Will a recording or plain-language recap of the Northern California panel be shared? That would give people who couldn't attend a way to catch up on the discussion. 30 views · 1 likes · 0 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D2 Sep

Clinical trials are bringing us closer to curing type 1 diabetes! Over the weekend, the Breakthrough T1D Northern California team hosted a Community Summit panel with Dr. Piotr Witkowski (University of Chicago), Dr. Gary Meininger (Sana Biotechnology), and moderator Karen https:

2.1K views · 13 likes · 2 reposts · 2 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

10 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 10K–100K ผู้ติดตาม การเข้าถึงปกติสำหรับขนาดนี้ แต่การตอบสนองอ่อนกว่าส่วนใหญ่.

ยอดดูมัธยฐาน1 716บัญชีนี้917ค่ามัธยฐานของ 10K–100K

การเข้าถึง, %2.73%บัญชีนี้3.39%ค่ามัธยฐานของ 10K–100K

การมีส่วนร่วม, %0.91%บัญชีนี้1.53%ค่ามัธยฐานของ 10K–100K

ตัวชี้วัด	บัญชีนี้	ค่ามัธยฐานของ 10K–100K	อัตราส่วน
ยอดดูมัธยฐานต่อโพสต์	1 716	917	1.87×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)	2.73%	3.39%	0.81×
อัตราการมีส่วนร่วม	0.91%	1.53%	0.59×

บัญชีอื่นในช่วงนี้ → เปรียบเทียบกับบัญชีอื่น → ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.1K2 Sep

453 Sep

1.9K

1.6K4 Sep

1.5K9 Sep

2.8K10 Sep

1.8K16 Sep

1.4K

2.3K17 Sep

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.82%2 Sep

3.33%

2.22%3 Sep

1.49%

1.70%4 Sep

0.32%9 Sep

0.72%10 Sep

0.79%16 Sep

0.28%

1.00%17 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.53%.

What the audience does

Likes71.5%108 in total

Reposts17.2%26 in total

Replies2.6%4 in total

Quotes2.0%3 in total

Bookmarks6.6%10 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

14 Sep

Daily snapshots since 14 Sep 2026; the dashed line is the starting count.